急性冠脉综合症PCI时氯比格雷的合理应用教学文稿.pptVIP

急性冠脉综合症PCI时氯比格雷合理应用;氯比格雷作用机制;氯比格雷作用重要参数; Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention ;Patients were randomly assigned to receive a 300-mg clopidogrel loading dose (n = 1053) or placebo (n = 1063) 3 to 24 hours before PCI. Thereafter, all patients received clopidogrel, 75 mg/d, through day 28. From day 29 through 12 months, patients in the loading-dose group received clopidogrel, 75 mg/d, and those in the control group received placebo. Both groups received aspirin throughout the study.;MAIN OUTCOME MEASURES: ;RESULTS ;CONCLUSIONS: ;Optimal